Organic & Biomolecular Chemistry
Communication
C. P. VanderMaelen and F. D. Yocca, Development of a 19 F. Crestey, M. Witt, J. W. Jaroszewski and H. Franzyk, Expedite
Presynaptic 5-HT1A Antagonist, Bioorg. Med. Chem. Lett.,
2003, 13, 285–288.
7 J. A. Burkhard, B. Wagner, H. Fischer, F. Schuler, K. Müller
Protocol for Construction of Chiral Regioselectively N-Protected
Monosubstituted Piperazine, 1,4-Diazepane, and 1,4-Diazocane
Building Blocks, J. Org. Chem., 2009, 74, 5652–5655.
and E. M. Carreira, Synthesis of Azaspirocycles and Their 20 M. Jida and S. Ballet, Efficient One-Pot Synthesis of
Evaluation in Drug Discovery, Angew. Chem., Int. Ed., 2010,
49, 3524–3527.
8 G. Guercio, A. M. Manzo, M. Goodyear, S. Bacchi, S. Curti
Enantiomerically
Piperazines from Readily Available α-Amino Acids, New J.
Chem., 2018, 42, 1595–1599.
Pure:
N
-Protected-α-Substituted
and S. Provera, Synthesis of the NK1 Receptor Antagonist 21 A. Dömling and Y. Huang, Piperazine Scaffolds via
GW597599. Part 2: Development of a Scalable Route to a
Key Chirally Pure Arylpiperazine, Org. Process Res. Dev.,
2009, 13, 489–493.
Isocyanide-Based Multicomponent Reactions, Synthesis,
2010, 17, 2859–2883.
22 M. C. O. Reilly and C. W. Lindsley,
A General,
9 D. J. Blythin, X. Chen, J. J. Piwinski, N. Shih, H. Shue,
J. C. Anthes and A. T. Mcphail, Synthesis and NK 1/NK 2
Enantioselective Synthesis of Protected Morpholines and
Piperazines, Org. Lett., 2012, 14, 12–15.
Binding Activities of
a Series of Diacyl-Substituted 23 T. D. Montgomery and V. H. Rawal, Palladium-Catalyzed
2-Arylpiperazines, Bioorg. Med. Chem. Lett., 2002, 12, 3161–
Modular Synthesis of Substituted Piperazines and Related
3165.
Nitrogen Heterocycles, Org. Lett., 2016, 18, 740–743.
10 H. Y. Li, Y. Jin, C. Morisseau, B. D. Hammock and 24 M. U. Luescher, C. V. T. Vo and J. W. Bode, SnAP Reagents
Y. Q. Long, The 5-Substituted Piperazine as a Novel
Secondary Pharmacophore Greatly Improving the Physical
for the Synthesis of Piperazines and Morpholines, Org.
Lett., 2014, 16, 1236–1239.
Properties of Urea-Based Inhibitors of Soluble Epoxide 25 S. Y. Hsieh and J. W. Bode, Silicon Amine Reagents for the
Hydrolase, Bioorg. Med. Chem., 2006, 14, 6586–6592.
Photocatalytic Synthesis of Piperazines from Aldehydes
11 M. W. Theresa, M. C. Terrence, C. M. Suzanne,
and Ketones, Org. Lett., 2016, 18, 2098–2101.
L. B. Rhonda, W. C. Michael, P. D. Joseph, H. Kelly, 26 S. Chamakuri, P. Jain, S. K. Reddy Guduru, J. W. Arney,
S. K. Kenneth, E. K. Nancy, M. K. Astrid, D. M. Scott,
A. O. Charles, L. P. David, R. Elaine, D. S. Michael,
S. Daksha, R. W. Francine, B. G. Jackson, L. G. Samuel,
D. H. George, I. O. Allen and L. S. Robert, 2-Substituted
K. R. Mackenzie, C. Santini and D. W. Young, Synthesis of
Enantiomerically Pure 6-Substituted-Piperazine-2-Acetic
Acid Esters as Intermediates for Library Production, J. Org.
Chem., 2018, 83, 6541–6555.
Piperazines as Constrained Amino Acids. Application to the 27 S. K. Reddy Guduru, S. Chamakuri, I. O. Raji,
Synthesis of Potent, Non Carboxylic Acid Inhibitors of
Farnesyltransferase, J. Med. Chem., 1996, 39, 1345–1348.
12 B. Shao, J. Huang, Q. Sun, K. J. Valenzano, L. Schmid and
S. Nolan, 4-(2-Pyridyl)Piperazine-1-Benzimidazoles as
K. R. MacKenzie, C. Santini and D. W. Young, Synthesis of
Enantiomerically Pure 3-Substituted Piperazine-2-Acetic
Acid Esters as Intermediates for Library Production, J. Org.
Chem., 2018, 83, 11777–11793.
Potent TRPV1 Antagonists, Bioorg. Med. Chem. Lett., 2005, 28 P. Jain, I. O. Raji, S Chamakuri, K. R. MacKenzie,
15, 719–723.
B. T. Ebright, C. Santini and D. W. Young, Synthesis of
Enantiomerically Pure 5-Substituted Piperazine-2-Acetic
Acid Esters as Intermediates for Library Production, J. Org.
Chem., 2019, 84, 6040–6064.
13 S. Yokoshima, K. Watanabe, F. Uehara, Y. Usui and
H. Tanaka, Asymmetric Synthesis of 2-Arylpiperazines,
Bioorg. Med. Chem. Lett., 2014, 24, 5749–5751.
14 M. Sánchez-Roselló, O. Delgado, N. Mateu, A. A. Trabanco, 29 C. Zhong, Y. Wang, C. O’Herin and D. W. Young, Synthesis
M. Van Gool and S. Fustero, Diastereoselective Synthesis of
2-Phenyl-3-(Trifluoromethyl)Piperazines as Building Blocks
for Drug Discovery, J. Org. Chem., 2014, 79, 5887–5894.
of Substituted Morpholines Using Stereodivergent Aza-
Michael Reactions Catalyzed by Brønsted Acids, ACS Catal.,
2013, 3, 643–646.
15 K. E. Gettys, Z. Ye and M. Dai, Recent Advances in 30 C. Zhong, Y. Wang, A. W. Hung, S. L. Schreiber and
Piperazine Synthesis, Synthesis, 2017, 49, 2589–2604.
16 S. H. Kwon, S. M. Lee, S. M. Byun, J. Chin and B. M. Kim,
Short Synthesis of Enantiopure Trans-3-Arylpiperazine-2-
D. W. Young, Diastereoselective Control of Intramolecular
Aza-Michael Reactions Using Achiral Catalysts, Org. Lett.,
2011, 13, 5556–5559.
Carboxylic Acid Derivatives via Diaza-Cope Rearrangement, 31 M. Yar, US2014/0323720 A1, p. 2014.
Org. Lett., 2012, 14, 3664–3667.
32 S. P. Fritz, J. V. Matlock, E. M. Mcgarrigle and
17 J. D. Firth, P. O’Brien and L. Ferris, Synthesis of
Enantiopure Piperazines via Asymmetric Lithiation-
Trapping of N-Boc Piperazines: Unexpected Role of the
V. K. Aggarwal, Efficient Synthesis of Cyclopropane-Fused
Heterocycles with Bromoethylsulfonium Salt, Chem. – Eur.
J., 2013, 19, 10827–10831.
Electrophile and Distal N-Substituent, J. Am. Chem. Soc., 33 M. Yar, E. M. McGarrigle and V. K. Aggarwal, An
2016, 138, 651–659.
Annulation Reaction for the Synthesis of Morpholines,
Thiomorpholines, and Piperazines from β-Heteroatom
Amino Compounds and Vinyl Sulfonium Salts, Angew.
Chem., Int. Ed., 2008, 47, 3784–3786.
18 Z. Ye, K. E. Gettys and M. Dai, Opportunities and
Challenges for Direct C–H Functionalization of
Piperazines, Beilstein J. Org. Chem., 2016, 12, 702–715.
This journal is © The Royal Society of Chemistry 2020
Org. Biomol. Chem.